Vasodilator compounds derived from plants and their mechanisms of action
- PMID: 23685938
- PMCID: PMC6270466
- DOI: 10.3390/molecules18055814
Vasodilator compounds derived from plants and their mechanisms of action
Abstract
The present paper reviews vasodilator compounds isolated from plants that were reported in the past 22 years (1990 to 2012) and the different mechanisms of action involved in their vasodilator effects. The search for reports was conducted in a comprehensive manner, intending to encompass those metabolites with a vasodilator effect whose mechanism of action involved both vascular endothelium and arterial smooth muscle. The results obtained from our bibliographic search showed that over half of the isolated compounds have a mechanism of action involving the endothelium. Most of these bioactive metabolites cause vasodilation either by activating the nitric oxide/cGMP pathway or by blocking voltage-dependent calcium channels. Moreover, it was found that many compounds induced vasodilation by more than one mechanism. This review confirms that secondary metabolites, which include a significant group of compounds with extensive chemical diversity, are a valuable source of new pharmaceuticals useful for the treatment and prevention of cardiovascular diseases.
Figures
Similar articles
-
Vasodilator Activity of Compounds Isolated from Plants Used in Mexican Traditional Medicine.Molecules. 2018 Jun 18;23(6):1474. doi: 10.3390/molecules23061474. Molecules. 2018. PMID: 29912156 Free PMC article.
-
Endothelium-dependent vasodilator effect of Euterpe oleracea Mart. (Açaí) extracts in mesenteric vascular bed of the rat.Vascul Pharmacol. 2007 Feb;46(2):97-104. doi: 10.1016/j.vph.2006.08.411. Epub 2006 Sep 1. Vascul Pharmacol. 2007. PMID: 17049314
-
The mechanism of vasorelaxation induced by ethanol extract of Sophora flavescens in rat aorta.J Ethnopharmacol. 2011 Sep 1;137(1):547-52. doi: 10.1016/j.jep.2011.06.013. Epub 2011 Jun 16. J Ethnopharmacol. 2011. PMID: 21704693
-
Endothelial dysfunction and vascular disease - a 30th anniversary update.Acta Physiol (Oxf). 2017 Jan;219(1):22-96. doi: 10.1111/apha.12646. Epub 2016 Jan 25. Acta Physiol (Oxf). 2017. PMID: 26706498 Review.
-
Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.Cardiovasc Drug Rev. 2007 Spring;25(1):30-45. doi: 10.1111/j.1527-3466.2007.00003.x. Cardiovasc Drug Rev. 2007. PMID: 17445086 Review.
Cited by
-
Structural characteristics, bioavailability and cardioprotective potential of saponins.Integr Med Res. 2018 Mar;7(1):33-43. doi: 10.1016/j.imr.2018.01.003. Epub 2018 Feb 3. Integr Med Res. 2018. PMID: 29629289 Free PMC article. Review.
-
(-)-Epicatechin Modulates Mitochondrial Redox in Vascular Cell Models of Oxidative Stress.Oxid Med Cell Longev. 2020 Jun 9;2020:6392629. doi: 10.1155/2020/6392629. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32587663 Free PMC article.
-
Vasodilator Activity of Compounds Isolated from Plants Used in Mexican Traditional Medicine.Molecules. 2018 Jun 18;23(6):1474. doi: 10.3390/molecules23061474. Molecules. 2018. PMID: 29912156 Free PMC article.
-
Quercetin Supplement to Aspirin Attenuates Lipopolysaccharide-Induced Pre-eclampsia-Like Impairments in Rats Through the NLRP3 Inflammasome.Drugs R D. 2022 Dec;22(4):271-279. doi: 10.1007/s40268-022-00402-6. Epub 2022 Sep 22. Drugs R D. 2022. PMID: 36136273 Free PMC article.
-
Vasorelaxant Effect of Trachelospermi caulis Extract on Rat Mesenteric Resistance Arteries.Molecules. 2022 Aug 19;27(16):5300. doi: 10.3390/molecules27165300. Molecules. 2022. PMID: 36014534 Free PMC article.
References
-
- Nguelefack T.B., Dongmo A.B., Dimo T., Kamanyi A. Phytopharmacology of Some Medicinal Plants Used in Cameroonian Traditional Medicine to Handle Cardiovascular Diseases. In: Capasso A., editor. Recent Developments in Medicinal Plants Research. Research Signpost Publisher; Kerala, India: 2007.
-
- Cogolludo A., Pérez-Vizcaíno F., Tamargo J. New insights in the pharmacological therapy of arterial hypertension. Curr. Opin. Nephrol. Hypertens. 2005;14:423–427. - PubMed
-
- Brunner H., Cockcroft J.R., Deanfield J. Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial factors of the European Society of Hypertension. J. Hypertens. 2005;23:233–246. doi: 10.1097/00004872-200502000-00001. - DOI - PubMed
-
- Dominiczak A.F., Bohr D.F. Nitric oxide and its putative role in hypertension. Hypertension. 1995;25:1202–1211. - PubMed
-
- Miles A.M., Bohle D.S., Glassbrenner P.A., Hansert B., Wink D.A., Grisham M.B. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J. Biol. Chem. 1996;271:40–47. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous